Sograzepide (Netazepide) (Synonyms: Netazepide; YF 476; YM-220) |
| Katalog-Nr.GC31407 |
Sograzepide (Netazepide) (Netazepide; YF 476; YM-220) ist ein extrem potenter, hochselektiver und oral aktiver Gastrin/CCK-B-Antagonist mit einem IC50-Wert von 0,1 nM, hat eine hemmende Wirkung auf die Gastrin/CCK-A-AktivitÄt mit einem IC50 von 502 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 155488-25-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Sograzepide (Netazepide;YF476) is a gastrin/cholecystokinin 2 receptor (CCK2) antagonist.
[1]. Boyce M, et al. Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects. Br J Clin Pharmacol. 2015 May;79(5):744-55.
Average Rating: 5 (Based on Reviews and 39 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *